Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $396M; returns 1 day +1.0%, 1 week +46.2%, 1 year -27.7%.

Myriad Genetics Inc. (MYGN) is a molecular diagnostic testing and precision medicine company that develops and commercializes molecular tests designed to assess disease risk and guide treatment decisions across various medical specialties. Myriad's portfolio includes tests for oncology, women's health, and pharmacogenomics.

Groups MYGN belongs to

• Healthcare
• Biotechnology
• Precision Medicine
• Health Diagnostics and Imaging
• Personalized Medicine
• Oncology
• Women's Health
• Life Sciences
• Healthcare Technology
• Medical Devices
• Mental Health Solutions
• Healthcare Services

MYGN financial model: income statement, cash flow and balance sheet